[Federal Register: March 24, 2008 (Volume 73, Number 57)]
[Notices]               
[Page 15528]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24mr08-75]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
The Centers for Disease Control and Prevention (CDC), Food and 
Drug Administration (FDA), and National Institutes of Health (NIH) 
Announce An Open Meeting Concerning Antimicrobial Resistance

    Name: A Public Health Action Plan to Combat Antimicrobial 
Resistance (Part I: Domestic Issues): Meeting for Public Comment on the 
Antimicrobial Resistance Interagency Task Force Annual Report.
    Times and Dates: 12:30 p.m.--2 p.m., Wednesday, June 25, 2008.
    Place: Hyatt Regency Bethesda, Bethesda, Maryland, One Bethesda 
Metro Center (7400 Wisconsin Ave), Bethesda, Maryland, USA 20814; Tel: 
1-301-652-2000; Fax: 1-301-652-4525).
    Status: Open to the public, limited only by the space available.
    Purpose: To present the annual report of progress by Federal 
agencies in accomplishing activities outlined in A Public Health Action 
Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues) and 
solicit comments from the public regarding the annual report. The 
Action Plan serves as a blueprint for activities of Federal agencies to 
address antimicrobial resistance. The focus of the plan is on domestic 
issues.
    Matters to be Discussed: The agenda will consist of welcome and 
introductory comments, an executive summary, and brief reports in four 
focus areas: Surveillance, Prevention and Control, Research, and 
Product Development. The Task Force will also provide a brief review of 
progress on updating the Action Plan. The meeting will then be open for 
comments from the general public.
    Comments and suggestions from the public for Federal agencies 
related to each of the focus areas will be taken under advisement by 
the Antimicrobial Resistance Interagency Task Force. The agenda does 
not include development of consensus positions, guidelines, or 
discussions or endorsement of specific commercial products.
    The Action Plan, Annual Report, and meeting agenda will be 
available at http://www.cdc.gov/drugresistance. The public meeting is 
sponsored by the CDC, FDA, and NIH in collaboration with seven other 
Federal agencies and departments that were involved in developing and 
writing A Public Health Action Plan to Combat Antimicrobial Resistance 
(Part I: Domestic Issues).
    Agenda items are subject to change as priorities dictate.
    Limited time will be available for oral comments, and suggestions 
from the public. Depending on the number wishing to comment, a time 
limit of three minutes may be imposed. In the interest of time, visual 
aids will not be permitted, although written material may be submitted 
for subsequent review by the Task Force. Written comments and 
suggestions from the public are encouraged and should be received by 
the contact person listed below prior to the opening of the meeting or 
no later than the end of July 2008.
    Persons anticipating attending the meeting are requested to send 
written notification to the contact person below by June 2, 2008, 
including name, organization (if applicable), address, telephone, fax, 
and e-mail address.
    Contact Person for More Information: Gregory J. Anderson, Office of 
Antimicrobial Resistance, CCID/CDC, Mailstop A-07, 1600 Clifton Road, 
NE., Atlanta, GA 30333; telephone 404-639-3539; fax 404-639-7444. E-
mail: gca5@cdc.gov.

    Dated: March 11, 2008.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention 
(CDC).
[FR Doc. E8-5858 Filed 3-21-08; 8:45 am]

BILLING CODE 4163-18-P